Abstract
In this issue of Blood, Hayden et al elegantly describe real-world data from their positron emission tomography (PET)-adapted treatment approach toward consolidative radiotherapy (RT) after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) in primary mediastinal B-cell lymphoma (PMBCL).
| Original language | English |
|---|---|
| Pages (from-to) | 2725-2726 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 136 |
| Issue number | 24 |
| DOIs |
|
| Publication status | Published - 10 Dec 2020 |
| Externally published | Yes |